; Bone Growth Products Market Opportunity and Demand till 2034

Bone Growth Products Market

Bone Growth Products Market Size, Share, and Analysis, By Product Type (Bone Growth Stimulator Device, Bone Morphogenic Protein, and Platelet Rich Plasma), By Applications (Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries, Delayed Union & Non-Union Bone Fracture, and Others), By End-User (Hospitals & Clinic, Specialty Orthopedic & Spine Center, and Ambulatory Surgery Centers), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

Published on: Sep-2024
Report Code: FG HC 02125
No. of Pages: 170-350
Report Format: PDF

Bone Growth Products Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 1.2 billion and is projected to reach USD 1.8 billion by the completion of 2034.

Product Overview

Bone growth products are medical therapies and equipment that stimulate the growth and healing of bone tissue. These items are often used in orthopedic and dental operations to help in the recovery of bone fractures and promote the regeneration of bones. In addition, important types of bone growth products involve bone grafts, which are important for the transplantation of bone tissue to encourage the production of new bone, and bone morphogenetic proteins (BMPs), which are proteins that stimulate the synthesis of new bone. Furthermore, scaffolding materials and bone substitutes can also be used to create a foundation for new bone formation.

Market Highlights

Bone Growth Products Market is expected to grow at a compound annual growth rate (CAGR) of 3.6% from 2024 to 2034

Ophthalmic implant market is projected to reach USD 1.8 billion over the forecast period, propelled by the growth of medical technology and the need for orthopedic and dental treatments that are efficient. In addition, biomaterial innovations, such as synthetic bone grafts and scaffolding, are helping to improve bone regeneration and healing. Moreover, growing awareness of treatment alternatives and the high prevalence of bone-related injuries is boosting the bone growth products market. In addition, one of the main factors driving the market is the development of new products with better performance, such as biocompatibility and faster integration with pre-existing bone tissue. Furthermore, as more products and treatment methods become accessible, patients and healthcare providers will have more options due to continuous research and clinical trials.

Source: Fatpos Global

Bone Growth Products Market Segmentation

Bone Morphogenic Protein segment will lead the industry as it encourages the formation of bones and is useful in healing

Bone growth products market is classified based on the Product Type into Bone Growth Stimulator Device, Bone Morphogenic Protein, and Platelet Rich Plasma. The Bone Morphogenic Protein (BMP) segment is leading the bone growth products market as they effectively stimulate bone formation through biological mechanisms and are essential for bone regeneration and healing. Moreover, they are used across surgical procedures as they can promote bone formation without the need for extra bone grafting, like spinal fusions and orthopedic surgeries. Their leading market position is a result of their clinical success as well as continuous improvements and research that improve their efficacy. Therefore, while platelet-rich plasma and bone growth stimulator devices are equally important, bone morphogenic proteins are the market leader due to their wide applications and demonstrated usefulness.

Spinal Fusion Surgeries segment will lead the market due to the growing prevalence of spinal surgeries across the world

Bone growth products market is divided by Application into Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries, Delayed Union & Non-Union Bone Fracture, and Others. The spinal fusion surgeries segment holds a dominant market share in the bone growth products market, owing to the high number of spinal surgeries conducted across the world. Advanced bone growth agents are frequently needed for spinal fusion surgeries to ensure the proper integration and healing of spinal implants. These goods include synthetic replacements and bone transplants, which are important for supporting bone growth and stabilizing the spine. Additionally, developments in surgical procedures and better patient outcomes are the main drivers of the demand for new solutions in spinal fusion surgery. Consequently, the impressive growth and the emphasis on less invasive techniques that can improve the effectiveness of bone growth products are responsible for contributing to the supremacy of the spinal fusion surgeries segment.

Source: Fatpos Global

Market Dynamics

Growth Drivers

Technological Progressions is Driving Growth in the Bone Growth Products Market

One of the main factors for the expansion of the bone growth products market is swift technological developments. Innovations in biomaterials, such as better synthetic bone grafts and advanced bone morphogenetic proteins (BMPs), are improving the capacity to stimulate bone mending and regeneration. In addition, better scaffold designs that perfectly blend in with natural bone to reduce recovery durations are major examples of technical innovation. These developments improve the results for patients and expand the application for bone growth materials. Furthermore, these technologies are expected to provide more effective and patient-friendly solutions, thus encouraging market growth and adoption of bone growth products.

Growing Prevalence of Bones Disorders Act as a Catalyst for Market Growth

As a result of the high occurrence of bone disorders, the market for bone growth products is growing at a large scale. Bone repair and regeneration solutions are in greater demand due to factors like an aging population, a high incidence of osteoporosis, and an increasing number of orthopedic injuries and spinal problems. Thus, better therapies that can promote bone healing and help in rehabilitation are needed as more people deal with health issues related to their bones. Furthermore, the need for new bone growth products is driven by the growing number of patients, which also promotes continuous R&D in this industry. Therefore, the market is expanding as patients, along with healthcare workers are seeking these solutions to address several bone health issues.

Restraints

Expensive Prices of New Technologies in the Market Will Impact the Growth

Expensive price of modern technologies is a major barrier to the market for bone growth goods. Large amounts of research and development are required for these products, which raises the cost of manufacturing. Due to this, some patients and healthcare providers may find the cost of bone development technologies to be unaffordable. The availability of these items may be restricted by their high cost across areas where insurance coverage for advanced treatments is scarce or healthcare budgets are tight. Hence, to overcome this limitation, strategies for reducing production costs while ensuring the quality of products must be developed.

Recent Developments

  • In July 2024, Medtronic announced the launch of the StealthStation S8 Surgical Navigation System, enhancing precision in spinal surgery with advanced imaging and navigation technologies.
  • In June 2024, Stryker acquired Nvision Biomedical Technologies, a company specializing in innovative bone growth products, expanding its portfolio in orthopedic solutions.
  • In August 2024, Zimmer Biomet introduced the T3 Platform, a new technology for spinal surgeries that integrates advanced imaging and navigation capabilities to improve surgical outcomes.
  • In April 2024, Smith & Nephew launched the REGENETEN Bioinductive Implant, a new product designed to enhance rotator cuff repair and improve healing through a bioinductive approach.
  • In May 2024, Orthofix International received FDA clearance for its CONVENTIONAL Bone Growth Stimulator, a device aimed at accelerating bone healing in patients with fractures or spinal fusions.

Bone Growth Products Market

Key Players:

  • DePuy Synthes (Johnson & Johnson)
  • Medtronic
  • Stryker Corporation
  • Zimmer Biomet
  • Smith & Nephew
  • Orthofix International
  • NuVasive
  • Globus Medical
  • MedeAnalytics
  • Exactech
  • B. Braun Melsungen AG
  • Xtant Medical
  • Bone Biologics
  • CryoLife
  • Amedica Corporation
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Regional Analysis

Bone Growth Products Market is segmented based on regional analysis into five key regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Due to its advanced healthcare system and huge R&D investments, North America leads the global market for bone growth products. In addition, strong insurance frameworks that encourage the use of modern bone development products, combined with rising orthopedic problems and an unshakable medical device industry are contributing to the development of the bone growth product market in the North American region.

Simultaneously, the aging population and the availability of advanced treatment options are contributing to the remarkable rise of the Asia Pacific region. Better healthcare solutions are becoming increasingly necessary due to urbanization and economic development efforts across the region. Furthermore, the bone growth products market is rising as a result of high investments in healthcare infrastructure and a rise in orthopedic treatments across the Asia Pacific region.

Source: Fatpos Global

Impact of COVID-19 on the Bone Growth Products Market

Bone growth products market saw conflicting effects from the COVID-19 epidemic. On the one hand, it caused cancellations of elective surgery, such as orthopedic procedures, which temporarily reduced the market for bone growth products. Moreover, sales were impacted, and the market's growth was temporarily stalled. Conversely, the pandemic brought attention to the importance of healthcare solutions and accelerated the adoption of digital tools, which further helped the market. Besides, the industry saw recovery as healthcare systems recovered, which increased the demand for new bone growth products to address the increasing need for efficient treatments.

Bone Growth Products Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and the Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Bone Growth Products Market Scope and Segments:

ATTRIBUTE

  DETAILS

Study Period

2018-2034

Base Year

2023

Forecast Period

2024-2034

Historical Period

2019-2022

Growth Rate

CAGR of 3.6% from 2024-2034

Unit

Value (USD Billion)

Segmentation

Main Segments List

By Product Type

  • Bone Growth Stimulator Device
  • Bone Morphogenic Protein
  • Platelet Rich Plasma

By Application

  • Spinal Fusion Surgeries
  • Oral & Maxillofacial Surgeries
  • Delayed Union & Non-Union Bone Fracture
  • Others

By End User

  • Hospitals & Clinic
  • Specialty Orthopedic & Spine Center
  • Ambulatory Surgery Centers

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions (FAQ):

Bone Growth Products Market size was valued at USD 1.2 billion in 2023 and is projected to reach the value of USD 1.8 billion in 2034, exhibiting a CAGR of 3.6% during the forecast period.

The Bone Growth Products Market encompasses a range of medical products designed to promote and enhance bone regeneration and repair.

The Bone Morphogenic Protein segment and Spinal Fusion Surgeries segment accounted for the largest Bone Growth Products Market share.

Key players in the Bone Growth Products Market include DePuy Synthes (Johnson & Johnson), Medtronic, Stryker Corporation, Zimmer Biomet, Smith & Nephew, Orthofix International, NuVasive, Globus Medical, MedeAnalytics, Exactech, B. Braun Melsungen AG, Xtant Medical, Bone Biologics, CryoLife, Amedica Corporation, and Other Players.

Technological progressions and the growing prevalence of bone disorders are the factors driving the ophthalmic implant market.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients